Home
>
Stock Market
>
>
Ennature Bio Pharma Ltd

Ennature Bio Pharma Ltd share price and stock overview

Ennature Bio Pharma Ltd (NSE: ENNATURE, BSE: 545012) operates in the Miscellaneous sector. The stock has an ISIN of INE2WCT01016 and a face value of Rs 5. As of 12 November 2026, it trades at Rs (204.55) with a market capitalisation of Rs 451.87 crore. Figures are live and subject to change.

Ennature Bio Pharma Ltd

Miscellaneous

NSE BSE

204.55 9.70 (4.98%) upARrowC

As on: 12-Nov-2026 , 04:30 PM

Market Cap(₹Cr) 451.87

Book Value(₹Cr) 4.9932415

BSE Code : 545012 NSE Symbol : ENNATURE EPS(TTM) : 0 ISIN Demat : INE2WCT01016 P/E(TTM) : 0 Face Value(₹) : 5 Div & Yield % : 0

Today Market

Stock Performance

Today Market

Today's High

82,325.61

Todday's Low

81,576.15

Open at

81,762.27

Previous Close

81,879.40

Volumes

0.00

Avg Price

31.61

Historical Performance

News

12 Nov 26

Ennature Bio Pharma appoints Amit Arora and others to key leadership roles

Ennature Bio Pharma Limited designated Amit Arora as Head- Sales & Marketing, Rakesh Kumar Srivastava as Head- Operations, Anand Gupta as Head- QA & RA, Prashant Babu as DGM- R&D, and Swatantresh Mishra as DGM- HR, effective November 12, 2026, according to a regulatory filing with the BSE Limited and National Stock Exchange of India Limited.

12 Nov 26

Ennature Bio Pharma adopts new Articles of Association pending approvals

Ennature Bio Pharma Limited announced that its Board of Directors approved the adoption of a new set of Articles of Association, intended to align with the Securities Contracts (Regulation) Rules, 1957, and the governance framework of the group, at a meeting held on November 12, 2026, subject to shareholder and regulatory approvals.

05 Nov 26

Ennature Bio Pharma to review Q2 financial results at board meeting November 12

Ennature Bio Pharma Limited will hold a board meeting on Thursday, November 12, 2026, to consider and approve the unaudited financial results for the second quarter ended September 30, 2026, according to a regulatory filing with the BSE Limited and National Stock Exchange of India Limited.

04 Nov 26

Ennature Bio Pharma closes securities trading window ahead of results declaration

Ennature Bio Pharma Limited informed the Bombay Stock Exchange and National Stock Exchange of India that the trading window for dealing in the company's securities will be closed from Wednesday, November 4, 2026, until 48 hours after the declaration of financial results for the quarter and half year ending September 30, 2026.

Historical Prices

Share Price Chart

Historical Share Price

Date	Open Price (₹)	High Price(₹)	Low Price(₹)	Close Price(₹)	Total Volume	No of Trades	Net Turnover(₹)	NIFTY
11-11-26	194.85	214.95	194.85	194.85	177695	1766	35098893.85	25255.05
09-11-26	205.10	205.10	205.10	205.10	15130	256	3103163.00	25044.65
08-11-26	215.85	215.85	215.85	215.85	4751	199	1025503.35	24986.40
06-11-26	227.20	227.20	227.20	227.20	3713	205	843593.60	25030.35
05-11-26	239.15	241.50	239.15	239.15	104613	922	25025026.90	24536.60
04-11-26	264.90	264.90	251.70	251.70	54233	563	13755872.70	23960.60

Fundamentals

Company Valuation

Market Cap (₹cr)

451.87

PE Ratio

PB Ratio

40.50

Dividend Yield

ROE

0.00

ROCE

0.00

Book Value (₹)

4.9932415

Face Value (₹)

Share Holding Pattern

Category of Shareholder	No of Shares	% Share Holdings	Demat Shares	Share Holders

Promoter & Group

Foreign

Foreign (Promoter & Group) - Bodies Corporate	11405373	51.05	11405373	3
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign)	0	0.00	0	0
Foreign Promoter(Institutional)	0	0.00	0	0
Promoter Others	0	0.00	0	0

Sub Total

11405373

51.05

11405373

Indian

Bodies Corporate-Indian (Promoter & Group)	0	0.00	0	0
Government(Central / State)-Indian (Promoter & Group)	0	0.00	0	0
Directors & their Relatives-Indian (Promoter & Group)	0	0.00	0	0
Financial Institutions / Banks-Indian (Promoter & Group)	0	0.00	0	0
Individuals / Hindu Undivided Family-Indian (Promoter & Group)	1917243	8.58	1917243	5
Partnership Firms-Indian (Promoter & Group)	0	0.00	0	0
Persons Acting in Concert	0	0.00	0	0
Trusts	0	0.00	0	0
Others	0	0.00	0	0

Sub Total

1917243

8.58

1917243

Total ShareHolding for Promoter & Group

13322616

59.63

13322616

Publice Share Holding

Institution

Government(Central / State)	66	0.00	66	1
Clearing Members	0	0.00	0	0
Corporate Bodies	0	0.00	0	0
Foreign Direct Investments	0	0.00	0	0
Financial Institutions / Banks	6	0.00	6	1
Foreign Bank	0	0.00	0	0
Foreign Bodies Corporate/OCBs/FBC	0	0.00	0	0
Foreign Collaborators	0	0.00	0	0
Foreign Institutional Investors	544856	2.44	544856	67
Foreign Venture Capital Investors	0	0.00	0	0
Foreign Institution Other	0	0.00	0	0
Insurance Companies	0	0.00	0	0
Mutual Funds / UTI	47399	0.21	47399	6
Individuals (Non-Resident / Foreign)	0	0.00	0	0
NSDL Intransit	0	0.00	0	0
Others	983003	4.40	983003	17
Trusts	0	0.00	0	0
Venture Capital Funds	0	0.00	0	0

Sub total

1575330

7.05

1575330

Non Institution

Bodies Corporate	901965	4.04	901965	538
Clearing Members	68148	0.31	68148	27
Directors & their Relatives	0	0.00	0	0
Employees	0	0.00	0	0
Escrow Account	0	0.00	0	0
Foreign Corporate Bodies	0	0.00	0	0
Foreign Direct Investments	0	0.00	0	0
NRIs/Foreign Individuals/Foreign Nationals	165997	0.74	165997	1141
Foreign Non Institution Other	0	0.00	0	0
Hindu Undivided Families	255845	1.15	255845	1354
Indian Public	0	0.00	0	0
Individuals holding nominal share capital in excess of Rs. 1 lakh	904028	4.05	904028	7
Individuals holding nominal share capital up to Rs. 1 lakh	4611607	20.64	4611607	45115
Market Maker	0	0.00	0	0
NSDL Transit	0	0.00	0	0
Shares in transit	0	0.00	0	0
Societies	0	0.00	0	0
Trust & Foundation	26412	0.12	26412	7
Others	309861	1.39	309861	1

Sub Total

7444309

33.32

7444309

48192

Total Public Shareholding

9019639

40.37

9019639

48284

Total of Promoter & Public ShareHolding

22342255

100.00

22342255

48292

Shares held by Custodians and against which Depository Receipts have been issued

ADR	0	0.00	0	0
GDR	0	0.00	0	0
Other Custodians	0	0.00	0	0

Total Shares held by Custodians and against which Depository Receipts have been issued

0.00

Grand Total

22342255

100.00

22342255

48292

Financials (₹ in cr)

Consolidated Standalone

No Data Available

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)	Mar 2026	Mar 2025	Mar 2024	Mar 2022
Share Capital	0.01	0.01	0.01	0.01
Reserves Total	-0.02	-0.01	-0.01	0.00
Equity Share Warrants	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00
Total Shareholders Funds	-0.01	0.00	0.00	0.01
Secured Loans	0.00	0.00	0.00	0.00
Unsecured Loans	0.00	0.00	0.00	0.00
Total Debt	0.00	0.00	0.00	0.00
Other Liabilities	0.00	0.00	0.00	0.00
Total Liabilities	-0.01	0.00	0.00	0.01
APPLICATION OF FUNDS :
Gross Block	0.00	0.00	0.00	0.00
Less : Accumulated Depreciation	0.00	0.00	0.00	0.00
Less:Impairment of Assets	0.00	0.00	0.00	0.00
Net Block	0.00	0.00	0.00	0.00
Lease Adjustment	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances
Inventories	0.00	0.00	0.00	0.00
Sundry Debtors	0.00	0.00	0.00	0.00
Cash and Bank Balance	0.00	0.00	0.00	0.01
Loans and Advances	0.00	0.00	0.00	0.00
Total Current Assets	0.00	0.00	0.00	0.01
Less : Current Liabilities and Provisions
Current Liabilities	0.01	0.00	0.00	0.00
Provisions	0.00	0.00	0.00	0.00
Total Current Liabilities & Provisions	0.01	0.00	0.00	0.00
Net Current Assets	-0.01	0.00	0.00	0.01
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.00	0.00	0.00	0.00
Net Deferred Tax	0.00	0.00	0.00	0.00
Other Assets	0.00	0.00	0.00	0.00
Total Assets	-0.01	0.00	0.00	0.01
Contingent Liabilities	0.00	0.00	0.00	0.00

Cash Flow (₹ in cr)

Yearly Cash Flow	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Financing Activities	0.01	0.00	0.00	0.00	0.00
Investing Activities	0.00	0.00	0.00	0.00	0.00
Net Cash Flow	0.01	0.00	0.00	0.00	0.00
Operating Activities	0.00	0.00	0.00	0.00	0.00

Peers

Balance Sheet Financial Ratios Profit & Loss

3rd Rock Multime...

Aarvi Encon Ltd

145.90

(-1.10%)

ABC India Ltd

ABG Shipyard Ltd

Accuracy Shippin...

4.11

(-0.48%)

ACE EduTrend Ltd

AceVector Ltd

19.70

(-0.96%)

Acewin Agriteck ...

Corporate Actions

Bonus Dividends Splits

Date	Corporate Action	Information
No Corporate Actions Announced

Board of Directors

Frequently Asked Questions

What is the NSE symbol and BSE code for Ennature Bio Pharma Ltd? −

Ennature Bio Pharma Ltd trades on NSE under ENNATURE and on BSE under code 545012. The ISIN is INE2WCT01016 and the face value is Rs 5.

What is the share price of Ennature Bio Pharma Ltd today? +

As of 12 November 2026, Ennature Bio Pharma Ltd trades at Rs 204.55, a change of 9.70 (4.98%) on the day. Prices are live and subject to change.

What is the market capitalisation of Ennature Bio Pharma Ltd? +

As of 12 November 2026, Ennature Bio Pharma Ltd has a market cap of about Rs 451.87 crore. This figure is live and moves with the share price.

Is Ennature Bio Pharma Ltd profitable? +

In , Ennature Bio Pharma Ltd reported a profit after tax of Rs crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Ennature Bio Pharma Ltd? +

: As of 12 November 2026, the PE (TTM) for Ennature Bio Pharma Ltd is 0 and the price-to-book ratio is 40.50. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Ennature Bio Pharma Ltd pay a dividend? +

As of 12 November 2026, the dividend yield for Ennature Bio Pharma Ltd is 0%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Ennature Bio Pharma Ltd? +

As of the latest disclosed pattern, promoters hold 59.63% of Ennature Bio Pharma Ltd. Public shareholding is 40.37%, including mutual funds at 0.21% and foreign institutional investors at 2.44%.

What were the latest annual financials of Ennature Bio Pharma Ltd? +

In , Ennature Bio Pharma Ltd reported net sales of Rs crore, revenue growth of %, and earnings per share of Rs .